Co-Located 10. Manufacturing and RA Strategy in Developing ADC and Multi-Specific Antibodies
Strategic Development of ADC and Multi-Specific Antibodies
In order to support ADC & Multi-specific Ab developing company by providing know-how in manufacturing by sharing experience from a CDMO, Shanghai OPM Bioscience, and updated information on ICH Q5A
Global trend of regulatory acceptance of the molecules and US FDA's point-of-view are also shared by key experts from Certara.
